Mayzent and Muscle strain - a phase IV clinical study of FDA data

Summary:

Muscle strain is reported as a side effect among people who take Mayzent (siponimod fumaric acid), especially for people who are female, 60+ old, also take Ampyra, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Muscle strain when taking Mayzent. It is created by eHealthMe based on reports of 10,267 people who have side effects when taking Mayzent from the FDA, and is updated regularly.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 10,269 Mayzent users. Check the latest studies of Mayzent.

What is Muscle strain?

Muscle strain (an injury to a muscle in which the muscle fibres tear) is found to be associated with 922 drugs and 827 conditions by eHealthMe. Check the latest studies of Muscle strain.

On Jul, 28, 2026

10,267 people reported to have side effects when taking Mayzent.
Among them, 15 people (0.15%) have Muscle strain.

Among these 15 people:

What is the gender of people who have Muscle strain when taking Mayzent? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Muscle strain when taking Mayzent? *

What are other drugs people take besides Mayzent? *

What are other side effects people have besides Muscle strain? *

Headache (pain in head): 10 people, 66.67%
Fall: 9 people, 60.00%
Fatigue (feeling of tiredness): 9 people, 60.00%
Weakness: 7 people, 46.67%
Muscle Spasms (muscle contraction): 6 people, 40.00%
Pain In Extremity: 6 people, 40.00%
Back Pain: 5 people, 33.33%
Dyspnea (difficult or laboured breathing): 5 people, 33.33%
Cataract (clouding of the lens inside the eye): 5 people, 33.33%
Peripheral Swelling: 5 people, 33.33%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 66.67%
Pain: 4 people, 26.67%
Gait Disturbance: 4 people, 26.67%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 3 people, 20.00%
Ill-Defined Disorder: 3 people, 20.00%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 13.33%
Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 2 people, 13.33%
Urinary Tract Disorder: 1 person, 6.67%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 6.67%
Micturition Urgency (urgency to pass the urine): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mayzent and have Muscle strain?

- Check whether Muscle strain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mayzent:

Mayzent (10,269 reports)

Muscle strain treatments and more:

Muscle strain (12,853 reports)

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Muscle strain:

Muscle strain (923 drugs)

Browse all the conditions that are associated with Muscle strain:

Muscle strain (827 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.